» Articles » PMID: 9058295

Mutations in a Hydrophilic Part of the Core Gene of Hepatitis C Virus in Patients with Hepatocellular Carcinoma in China

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 1997 Feb 1
PMID 9058295
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the association between hepatocellular carcinoma (HCC) and the genomic characteristics of the hepatitis C virus (HCV) isolated from residents of the inshore region of the Yangtze River, an area that has one of the highest incidence of HCC in China. We determined the genomic heterogeneity of HCV, and the sequence divergence of the HCV core gene in individuals with chronic hepatitis and HCC. HCV genotype II was predominant among these isolates, which were homologous to other Chinese and Japanese HCV isolates. The rate of nucleotide substitutions in the core gene was significantly greater for isolates from HCC patients than for those from individuals with chronic hepatitis. The nucleotide substitutions were unevenly scattered along the core gene; a cluster of missense mutations was apparent in the region encoding the second hydrophilic domain of the core protein. The rate of occurrence of missense mutations per nucleotide substitution was significantly greater in this clustering variable region (CVR) of the core gene than in the remaining core gene sequence. These observations suggest that mutations in the CVR may be involved in the pathogenesis of chronic HCV infection during hepatocellular carcinogenesis.

Citing Articles

Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis.

Dong Z, Yao M, Zhang H, Wang L, Huang H, Yan M Oncol Lett. 2013; 7(1):28-34.

PMID: 24348815 PMC: 3861549. DOI: 10.3892/ol.2013.1663.


Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma.

Hu Z, Muroyama R, Kowatari N, Chang J, Omata M, Kato N Cancer Sci. 2010; 100(12):2465-8.

PMID: 20175782 PMC: 11158212. DOI: 10.1111/j.1349-7006.2009.01338.x.


Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.

Dong Z, Yao D, Yao D, Wu X, Wu W, Qiu L World J Gastroenterol. 2005; 11(30):4655-60.

PMID: 16094705 PMC: 4615406. DOI: 10.3748/wjg.v11.i30.4655.


Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.

Ogata S, Nagano-Fujii M, Ku Y, Yoon S, Hotta H J Clin Microbiol. 2002; 40(10):3625-30.

PMID: 12354856 PMC: 130847. DOI: 10.1128/JCM.40.10.3625-3630.2002.


Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions.

Walewski J, Gutierrez J, Branch-Elliman W, Stump D, Keller T, Rodriguez A RNA. 2002; 8(5):557-71.

PMID: 12022223 PMC: 1370277. DOI: 10.1017/s1355838202029023.


References
1.
Pasternack M . Cytotoxic T-lymphocytes. Adv Intern Med. 1988; 33:17-44. View

2.
Colombo M, Rumi M, Donato M, Tommasini M, Del Ninno E, Ronchi G . Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Dig Dis Sci. 1991; 36(8):1130-3. DOI: 10.1007/BF01297459. View

3.
Takamizawa A, Mori C, FUKE I, Manabe S, Murakami S, Fujita J . Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991; 65(3):1105-13. PMC: 239876. DOI: 10.1128/JVI.65.3.1105-1113.1991. View

4.
Hsu I, Metcalf R, Sun T, Welsh J, Wang N, Harris C . Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991; 350(6317):427-8. DOI: 10.1038/350427a0. View

5.
Chuang W, Omata M, Ehata T, Yokosuka O, Ito Y, Imazeki F . Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology. 1993; 104(1):263-71. DOI: 10.1016/0016-5085(93)90861-6. View